Submit site search
  • Study Adds to Evidence That Parkinson’s Starts in the Gut

    This story reports on new findings from Team Sulzer that indicates that PD begins in the gut and that what triggers initial gastrointestinal changes in Parkinson’s could be a misdirected immune attack.

  • Dopamine Neurons May Be More Diverse Than Thought

    Parkinson’s News Today discusses a cellular study of mice by Team Awatramani that found that a specific subset of dopamine-producing nerve cells in the brain appear to respond to movement acceleration and correspond with the region where cell death is particularly pronounced in PD.

  • Parkinson’s Disease: Essential Role in Neuroinflammation Found for a Subset of Brain Macrophages

    Team Sulzer used a mouse model of Parkinson’s disease to show that border-associated macrophages — not microglia — mediate the neuroinflammatory response in the brain.

  • Finding Rewrites Understanding Into Parkinson’s Disease Pathway

    This news story reports on a study by Team Hurley that solves a mystery about how the protein Optineurin recognizes unhealthy mitochondria “tagged” by PINK1 and Parkin, enabling their delivery to our body's garbage disposal system.

  • Red/Yellow Brain Pigment Linked to Parkinson’s Disease: Study

    This story discusses a study by Team Chen that found that people with Parkinson’s disease have higher than normal levels of a nerve cell-damaging red/yellow pigment called pheomelanin in their substantia nigra, the area of the brain that’s mainly affected by the neurodegenerative disease.

  • New Study Puts Gut Microbiome at the Center of Parkinson’s Disease Pathogenesis

    Science Daily covers a study by Team Liddle that says that the gut microbiome is involved in multiple pathways in the pathogenesis of Parkinson's disease.

  • Metagenomics of Parkinson’s Disease Implicates the Gut Microbiome in Multiple Disease Mechanisms

    This podcast episode features Haydeh Payami from Team Liddle and discusses how the gut microbiome may play a role in Parkinson's disease according to metagenomics.

  • 2022: A Year in Review

    ASAP reflects on the progress made in 2022 toward our vision of advancing collaborative, transparent research processes and environments that deliver faster and better outcomes in Parkinson’s disease research.

  • Congratulations to the 2022 COSA Prize Recipients

    ASAP’s second annual Celebration of Scientific Achievement (COSA) showcased the outstanding contributions of young investigators across our Collaborative Research Network (CRN). This year’s event attracted over 400 participants, with 140 abstracts being showcased from across the network.

  • Yale Scientists Will Use $9M Grant to Create Map of Gut-brain Axis

    Parkinson's News Today reports on ASAP Team Hafler's goal of generating a detailed map of the “gut-brain axis,” the complex communication route between brain and belly — focusing on the gut microbiome — that is increasingly thought to play a key role in Parkinson’s and other neurodegenerative diseases.

  • First ASAP In-Person Meeting

    It was a reunion for some and a first union for many as members of ASAP’s Collaborative Research Network (CRN) gathered for their inaugural in-person meeting in early April.

  • Probing a Parkinson’s Paradox

    An ASAP research initiative digs into the mystery of paradoxical kinesia—the swift movement in patients whose motor functions are impaired by Parkinson’s Disease.

  • 2 Northwestern Researchers Awarded $17.9M in ASAP Grants

    Check out this article from Parkinson's News Today to learn more abut how ASAP Team Awatramani's research is focusing on brain circuits, the specific populations of interconnected brain cells that carry out functions together, and how particular circuits may be affected in Parkinson’s.

Load More